PortfoliosLab logoPortfoliosLab logo
LABD vs. BRKL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

LABD vs. BRKL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Corgi BRKB 2x Daily ETF (BRKL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


LABD

1D
8.48%
1M
26.56%
6M
-50.76%
YTD
-55.11%
1Y
-85.49%
3Y*
-58.18%
5Y*
-46.59%
10Y*
-56.42%
ALL TIME*
-55.10%

BRKL

1D
0.85%
1M
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$853.16$14.75K$14.75K
$66.43M$107.77M$90.23M

LABD vs. BRKL - Yearly Performance Comparison


Correlation

The correlation between LABD and BRKL is 0.35, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 7, 2026

0.35

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LABD vs. BRKL — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

LABD
LABD Risk / Return Rank: 11
Overall Rank
LABD Sharpe Ratio Rank: 11
Sharpe Ratio Rank
LABD Sortino Ratio Rank: 00
Sortino Ratio Rank
LABD Omega Ratio Rank: 00
Omega Ratio Rank
LABD Calmar Ratio Rank: 11
Calmar Ratio Rank
LABD Martin Ratio Rank: 22
Martin Ratio Rank

BRKL

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

LABD vs. BRKL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Corgi BRKB 2x Daily ETF (BRKL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LABDBRKLDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.72

Calmar ratioReturn relative to maximum drawdown

-0.96

Martin ratioReturn relative to average drawdown

-1.28

LABD vs. BRKL - Sharpe Ratio Comparison


Loading charts...

Drawdowns

LABD vs. BRKL - Drawdown Comparison

The maximum LABD drawdown since its inception was -100.00%, which is greater than BRKL's maximum drawdown of -7.03%. Use the drawdown chart below to compare losses from any high point for LABD and BRKL.


Loading charts...

Drawdown Indicators


LABDBRKLDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-7.03%

-92.97%

Max Drawdown (1Y)

Largest decline over 1 year

-89.59%

Max Drawdown (3Y)

Largest decline over 3 years

-97.43%

Max Drawdown (5Y)

Largest decline over 5 years

-99.04%

Max Drawdown (10Y)

Largest decline over 10 years

-99.99%

Current Drawdown

Current decline from peak

-99.99%

-0.13%

-99.86%

Average Drawdown

Average peak-to-trough decline

-91.08%

-4.14%

-86.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

67.04%

Volatility

LABD vs. BRKL - Volatility Comparison


Loading charts...

Volatility by Period


LABDBRKLDifference

Volatility (1M)

Calculated over the trailing 1-month period

24.34%

Volatility (6M)

Calculated over the trailing 6-month period

65.59%

Volatility (1Y)

Calculated over the trailing 1-year period

80.29%

30.99%

+49.30%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

96.73%

30.99%

+65.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

95.74%

30.99%

+64.75%

LABD vs. BRKL - Expense Ratio Comparison

LABD has a 1.06% expense ratio, which is higher than BRKL's 0.45% expense ratio.


Dividends

LABD vs. BRKL - Dividend Comparison

LABD's dividend yield for the trailing twelve months is around 7.00%, while BRKL has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018
BRKL
Corgi BRKB 2x Daily ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LABD
Direxion Daily S&P Biotech Bear 3x Shares
7.00%6.67%4.68%6.13%0.53%0.00%3.94%1.75%0.81%

Frequently Asked Questions


LABD and BRKL have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, BRKL is cheaper at 0.45% per year. The better choice depends on whether you care most about return, fees, risk, or income.

BRKL is cheaper with a 0.45% expense ratio, compared with 1.06% for LABD.

LABD has the higher dividend yield at 7.00%, compared with 0.00% for BRKL.

They also come from different issuers: Direxion and Corgi. Their fees differ too: 1.06% for LABD and 0.45% for BRKL.

Portfolio Optimizer

Find the right allocation for LABD and BRKL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer